-+ 0.00%
-+ 0.00%
-+ 0.00%

POLYRIZON STRUCTURES CLINICAL STRATEGY FOR ITS ALLERGY BLOCKER AHEAD OF FDA PRE-SUBMISSION MEETING

Reuters·03/27/2025 12:25:00

Please log in to view news